Rare diseases
Investigational molecules
Locations
Study of AFM24 and Atezolizumab for Patients with Advanced or Metastatic EGFR-expressing Cancers
PolandStudy on Advanced Liver Cancer: Evaluating Livmoniplimab and Budigalimab in Patients Without Prior Systemic Treatment
FranceStudy on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy
FranceStudy of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Not Had Chemotherapy
FranceStudy of Atezolizumab and Tiragolumab for Patients with Resectable Solid Tumors at Intermediate-High Risk of Recurrence
SpainStudy of RO7247669, Tiragolumab, and Atezolizumab for Patients with Untreated Advanced Urothelial Cancer Ineligible for Platinum Chemotherapy
DenmarkStudy of Atezolizumab and Tiragolumab with Chemoradiotherapy for Patients with Localized Anal Canal Squamous Cell Carcinoma
SpainStudy of Tiragolumab, Atezolizumab, and Pembrolizumab for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer
BelgiumStudy on the Safety and Effectiveness of Mosunetuzumab and Atezolizumab for Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
GermanyStudy on Atezolizumab with Radiotherapy for Patients with Muscle-Invasive Bladder Cancer
SpainStudy of Atezolizumab and Bevacizumab for Patients with High-Risk Hepatocellular Carcinoma After Surgery or Ablation
AustriaStudy on the Effects of Pembrolizumab, Atezolizumab, and Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
